STAAR Surgical Company (SR3)
FSX
Real-time Data
06:00 AM
Day's Range
19.4852 wk Range
13.51Overview - SR3 - STAAR Surgical Company
Key Statistics
Valuation
Enterprise Value
716.07M
P/E (Trailing)
‪270.71‬
P/E (Forward)
‪24.61‬
PEG Ratio
‪-1.84‬
Price / Sales (TTM)
‪2.79‬
Price / Book
‪2.91‬
EV / EBITDA
‪16.17‬
Profitability
Gross Margin
‪74.54%‬
Profit Margin
‪1.13%‬
Operating Margin
‪10.88%‬
Return on Assets
‪5.64%‬
Return on Equity
‪1.09%‬
Ownership
Shares Outstanding
50.12M
Float
26.12M
Held by Insiders
‪0.85%‬
Held by Institutions
‪111.71%‬
Price stats
Beta
‪1.17‬
50-Day Avg
‪19.76‬
200-Day Avg
‪20.31‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - SR3 - STAAR Surgical Company
Peers - SR3 - STAAR Surgical Company
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - SR3 - STAAR Surgical Company
About
STAAR Surgical Company is a medical technology company that designs, develops, manufactures, and markets implantable lenses for the eye and companion delivery systems. Its core product line includes Implantable Collamer® Lenses used in refractive surgery to address visual disorders such as myopia, hyperopia,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
